Evaluation of Buprenorphine CEDIA Assay versus GC–MS and ELISA using Urine Samples from Patients in Substitution Treatment

By Böttcher Michael  

Journal of Analytical Toxicology, Vol. 29, Iss. 8, 2005-11 ,pp. : 769-776

Oxford University Press

Access to resources Recommend Favorite

Development and GC–MS Validation of a Highly Sensitive Recombinant G6PDH-Based Homogeneous Immunoassay for the Detection of Buprenorphine and Norbuprenorphine in Urine

By Wang Guohong  

Journal of Analytical Toxicology, Vol. 31, Iss. 7, 2007-09 ,pp. : 377-382

Oxford University Press

Access to resources Recommend Favorite

Comparison of an Automated and Point-of-Care Immunoassay to GC–MS for Urine Oxycodone Testing in the Clinical Laboratory

By Haller Christine A.  

Journal of Analytical Toxicology, Vol. 30, Iss. 2, 2006-03 ,pp. : 106-111

Oxford University Press

Access to resources Recommend Favorite

TECHNICAL NOTE: Evaluation of the Cedia® Heroin Metabolite (6-AM) Immunoassay with Urine Specimens from a Criminal Justice Drug-Testing Program

By Jenkins Amanda J.  

Journal of Analytical Toxicology, Vol. 29, Iss. 3, 2005-04 ,pp. : 201-204

Oxford University Press

Access to resources Recommend Favorite

Cozart(r) RapiScan Oral Fluid Drug Testing System: An Evaluation of Sensitivity, Specificity, and Efficiency for Cocaine Detection Compared with ELISA and GC-MS Following Controlled Cocaine Administration

By Kolbrich Erin A.  

Journal of Analytical Toxicology, Vol. 27, Iss. 7, 2003-10 ,pp. : 407-411

Oxford University Press

Access to resources Recommend Favorite